<DOC>
	<DOCNO>NCT01671462</DOCNO>
	<brief_summary>The purpose study compare result Becton Dickinson ( BD ) Human Papilloma Virus ( HPV ) Assay Viper LT instrument SurePath medium dilute HPV diluent ( pre-quot and/or residual ) , PreservCyt medium dilute HPV diluent ( pre-quot and/or residual ) BD cervical brush BD transport medium reference histology result biopsy .</brief_summary>
	<brief_title>European Clinical Evaluation BD HPV Assay BD Viper LT System</brief_title>
	<detailed_description>This multicenter study consist 2-3 European clinical trial site , 2 BD Viper LT Systems . The BD HPV Diluent tube run BD HPV assay Viper LT instrument compare histology , Digene hybrid capture 2 ( HC2 ) , Roche LINEAR ARRAY HPV Genotyping Test result .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>Referred follow due one abnormal Pap HPV infection Subjects provide informed consent Subjects meet minimum age set forth ethic committee ( EC ) and/or national screening guideline . Known pregnant With prior complete partial hysterectomy involve removal cervix Subjects application chemical compound cervical area 24 hour prior study entry include acetic acid , iodine , spermicide , douche , antifungal med . Subjects conization , Loop electrosurgical excision procedure ( LEEP ) , laser surgery cryosurgery perform .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>HPV</keyword>
	<keyword>Cervical Cancer</keyword>
	<keyword>Cervical Neoplasms</keyword>
</DOC>